The 7 analysts offering 12-month price forecasts for Collegium Pharmaceutical Inc have a median target of 28.00, with a high estimate of 36.00 and a low estimate of 18.00. The median estimate represents a +55.64% increase from the last price of 17.99.
The current consensus among 7 polled investment analysts is to Buy stock in Collegium Pharmaceutical Inc. This rating has held steady since November, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share $1.05
Reporting Date Mar 10
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.